Published in
Taylor & Francis, Expert Opinion on Investigational Drugs, 7(24), p. 929-947
DOI: 10.1517/13543784.2015.1035708
Links
Tools
Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges
Journal article published in 2015 by
Vittore Cereda,
Vincenzo Formica,
Antonello Menghi,
Stefania Pellicori,
Mario Roselli 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 